• 13185 Citations
1984 …2018
If you made any changes in Pure these will be visible here soon.

Personal profile

Certifications and Licenses

1984Internship, Wellesley Hospital, Toronto
1989Residency, Toronto University Hospital, Canada
1990Fellowship, Toronto University Hospital, Canada
1991Postdoctoral Fellowship, University of Iowa
1991Postdoctoral Fellowship, University of Iowa
1991Fellowship, Univ. of Iowa Hospitals & Clinics
Surgery

Education/Academic qualification

MBA, Northwestern University

… → 2000

MD, University of Toronto

… → 1983

Keywords

  • Transplantation

Fingerprint Fingerprint is based on mining the text of the experts' scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 33 Similar Profiles
Transplants Medicine & Life Sciences
Liver Transplantation Medicine & Life Sciences
Liver Medicine & Life Sciences
Kidney Medicine & Life Sciences
Living Donors Medicine & Life Sciences
Kidney Transplantation Medicine & Life Sciences
Tissue Donors Medicine & Life Sciences
Hepatocellular Carcinoma Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1984 2018

61 Citations

AASLD guidelines for the treatment of hepatocellular carcinoma

Heimbach, J. K., Kulik, L. M., Finn, R. S., Sirlin, C. B., Abecassis, M. M., Roberts, L. R., Zhu, A. X., Murad, M. H. & Marrero, J. A. Jan 1 2018 In : Hepatology. 67, 1, p. 358-380 23 p.

Research output: Contribution to journalArticle

Liver Neoplasms
Hepatocellular Carcinoma
Guidelines

Incidence and Risk Factors of Intracranial Hemorrhage in Liver Transplant Recipients

Gallagher, T. K., Thomas, K. A., Ladner, D. P., Ganger, D., Sorond, F. A., Prabhakaran, S., Abecassis, M. M., Fryer, J. P. & Liotta, E. M. Mar 1 2018 In : Transplantation. 102, 3, p. 448-453 6 p.

Research output: Contribution to journalArticle

Intracranial Hemorrhages
Hemorrhage
Liver
Incidence
Odds Ratio
1 Citations

Institutional decision to adopt Y90 as primary treatment for hepatocellular carcinoma informed by a 1,000-patient 15-year experience

Salem, R. , Gabr, A. , Riaz, A. , Mora, R. , Ali, R. , Abecassis, M. , Hickey, R. , Kulik, L. , Ganger, D. , Flamm, S. , Atassi, R. , Atassi, B. , Sato, K. , Benson, A. B. , Mulcahy, M. F. , Abouchaleh, N. , Asadi, A. A. , Desai, K. , Thornburg, B. , Vouche, M. & 7 others Habib, A., Caicedo, J., Miller, F. H., Yaghmai, V., Kallini, J. R., Mouli, S. & Lewandowski, R. J. Jan 1 2018 (Accepted/In press) In : Hepatology.

Research output: Contribution to journalArticle

Liver Neoplasms
Hepatocellular Carcinoma
Confidence Intervals
Survival
Therapeutics
Liver Neoplasms
Survival Analysis
Blood Vessels
Hepatocellular Carcinoma
Neoplasm Metastasis

The “opportunity costs” of kidney transplantation

Jay, C. L. & Abecassis, M. M. May 1 2018 In : American Journal of Transplantation. 18, 5, p. 1044-1045 2 p.

Research output: Contribution to journalEditorial

Kidney Transplantation
Costs and Cost Analysis